FreshRSS

🔒
❌ Acerca de FreshRSS
Hay nuevos artículos disponibles. Pincha para refrescar la página.
AnteayerTus fuentes RSS

Prehabilitation of frail elderly PAtients undergoing majoR surgEry at HOME (PREPARE-HOME): a superiority parallel-group randomised controlled trial protocol evaluating smart wearable enhanced prehabilitation versus usual care

Por: Leong · Y. H. · Tay · V. Y. J. · Yang · X. · Tan · C. J. · Au-Yong · P.-S. · Sim · J. L. X. · Ng · R. R. G. · Ong · M. E. H. · Tan · B. P. Y. · Abdullah · H. R. · Ke · Y.
Introduction

Frailty is a key predictor of adverse surgical outcomes in older adults, contributing to increased postoperative complications, prolonged hospitalisation and delayed recovery. Prehabilitation—targeting improvements in physical function before surgery—can mitigate these risks. However, traditional programmes often face low adherence due to logistical barriers. Integrating smart wearable devices into tele-supervised, home-based prehabilitation may enhance adherence, engagement and clinical outcomes.

This trial protocol describes the PREhabilitation of frail elderly PAtients undergoing majoR surgEry at HOME study with the objective to evaluate the effectiveness of a wearable-enhanced, tele-supervised prehabilitation programme (swSEP) versus standard care (unsupervised prehabilitation, uSEP) on improving preoperative functional capacity and postoperative outcomes in frail older adults undergoing major elective surgery.

Methods and analysis

This single-centre, prospective, randomised controlled trial will enrol 190 patients aged ≥65 years scheduled for major elective, non-cardiac surgery at Singapore General Hospital. Participants with frailty (Edmonton Frail Scale ≥6) will be randomised 1:1 to either the swSEP group (tele-supervised exercise with Fitbit Inspire 3 monitoring) or the uSEP group (standard physiotherapy education, exercise booklet and inspiratory muscle training if maximal inspiratory pressure 2O). The primary outcome is change in 6 min walk test distance from baseline to 1–3 days presurgery. Secondary outcomes include 30 s sit-to-stand test, handgrip strength, postoperative complications (per American College of Surgeons National Surgical Quality Improvement Program), hospital length of stay, readmissions, five-level version of the EuroQol five-dimensional questionnaire (EQ-5D-5L) and adherence. Data will be analysed using t-tests, analysis of covariance, logistic regression and Cox models, with stratification by baseline nutritional status.

Ethics and dissemination

Approved by the SingHealth Institutional Review Board (CIRB Ref: 2024/2242). Trial registered on ClinicalTrials.gov (NCT06633614). Results will be disseminated via peer-reviewed publications and academic conferences. Contact: irb@singhealth.com.sg

Trial registration number

ClinicalTrials.gov Identifier: NCT06633614

Efficacy of a mobile app-based intervention to improve eating behaviours and lifestyle in infants of mothers with metabolic risk factors: study protocol of a randomised controlled trial

Por: Chan · D. · Leong · K. · Ong · C. · Ku · C. W. · Chan · J. K. Y. · Chua · M. C. · Yap · F. · Loy · S. L.
Introduction

Childhood obesity has surged globally, leading to various metabolic comorbidities and increased cardiovascular risks. Early intervention in lifestyle and feeding practices during infancy is crucial to mitigate these risks. This study evaluates the efficacy of a mobile web app-based intervention tool, named the Feeding, Lifestyle, Activity Goals (FLAGs) to promote healthier eating behaviours and lifestyle habits in infants from birth to 12 months.

Methods and analysis

This two-arm randomised controlled trial will enrol 220 caregiver-infant pairs per arm at KK Women’s and Children’s Hospital, Singapore, with recruitment expected from January to December 2025. Eligible participants include women at ≥34 weeks’ gestation or up to 3 days post delivery with pre-pregnancy overweight/obesity (body mass index (BMI) >23 kg/m2) and/or a diagnosis of diabetes. Caregiver-infant pairs will be randomised to the FLAGs intervention or control group. Over 12 months, both groups will receive standard infant care. The intervention group will undergo regular assessments via the FLAGs web app built-in assessment tool, assessing infant feeding practices, sedentary behaviour and physical activity. The intervention group will also receive FLAGs personalised guidance and weekly digital nudges. Maternal and infant data will be collected at baseline and at 12 months. Primary outcomes are infant BMI, weight-for-length and body composition at 12 months. Secondary outcomes include lifestyle behaviours and eating habits assessed through validated questionnaires when the infants are 1 year old. We will perform both intention-to-treat and per protocol analysis.

Ethics and dissemination

Ethical approval has been obtained from the SingHealth Centralised Institutional Review Board (Ref: 2024/3224). Written informed consent will be obtained from all participants. Study findings will be disseminated via peer-reviewed publications and academic conferences, with de-identified data available on reasonable request. This trial is registered on ClinicalTrials.gov (ID: NCT06457750).

Trial registration number

NCT06457750.

Im Co-development of a Post-Acute Care Intervention for Frailty using Information and Communication technology (PACIFIC): a development process protocol

Por: Griffith · L. E. · Macedo · L. · Lokker · C. · Innes · A. · Leong · D. · Beauchamp · M. · Bosch · J. · Bray · S. R. · Lafortune · L. · Ma · J. · Marcucci · M. · Papaioannou · A. · Siu · H. Y.-H. · Alvarez · E. · Anderson · L. N. · Bassim · C. · Costa · A. P. · Crawshaw · J. · Dhillon · J.
Introduction

Hospitalisation is one of the most stressful life events for older adults, particularly for those who are pre-frail or frail. Multi-component community-based interventions have the potential to address the complex needs of older adults post-acute care admission. While some available interventions have been developed with end-user engagement, fully involving older people who are pre-frail or frail in the design of interventions has been less common. Multi-component community-based interventions that address the needs of older adults and their care partners with potential implementation barriers informed by healthcare providers, community partners and health system decision makers are needed. This protocol paper describes the planned process of co-designing for older patients discharged into the community, a Post-Acute Care Intervention for Frailty using Information and Communication technology.

Methods and analysis

The development of a complex multi-component frailty intervention which meets older people’s needs involves several concurrent tasks and methodologies, each informed by co-design and conducted with consideration to eventual implementation. These tasks include: (1) establishing a Research Advisory Board, (2) assessing the feasibility and validity of using hospital administrative data to identify frail or pre-frail older adults and their needs, (3) conducting a needs assessment of patients returning to the community, (4) mapping community assets to identify existing programmes and services to help tailor the intervention, (5) co-designing a multicomponent frailty intervention, (6) selecting study outcome measures and (7) selecting and tailoring a digital health patient portal to support intervention delivery, data capture and communication.

Ethics and dissemination

Each task requiring ethics approval will be submitted to the Hamilton Integrated Research Ethics Board at McMaster University. Results will be disseminated through peer-reviewed journal articles, conferences and networks of relevant knowledge users who have the capacity to promote dissemination of the results. A toolkit will be developed to help researchers and healthcare providers replicate the methodology for other populations.

Medication Management Services for Dialysis Patients: Impact on Clinical, Economic and Humanistic Outcomes—An Integrative Review

ABSTRACT

Aim

To synthesise evidence on the types of Medication Management Services (MMS) and establish the effect of the different MMS interventions on Economic, Clinical and Humanistic Outcomes (ECHO) in dialysis patients.

Design

Integrative review.

Data Sources

A systematic search was conducted from May to June 2024 using four databases: PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library and Web of Science.

Methods

This review followed Whittemore and Knafl's framework and adhered to the PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Data extraction and quality assessment were independently conducted by three reviewers using the Joanna Briggs Institute Critical Appraisal Tool and the Quality Improvement Minimum Quality Criteria Set. Only English-language articles, primary and quality improvement studies were included, with no restrictions on publication date. Findings were narratively synthesised and thematically grouped by review aims.

Results

A total of 14 articles were included. This review identified (1) the types of MMS provided to renal dialysis patients, and (2) the effects of these services on ECHO. Services varied in practices, including obtaining accurate medication histories, identifying discrepancies, reviewing laboratory results, making recommendations to prescribers, resolving issues based on collaborative agreements and providing patient education. These services were compared in terms of economic outcomes (e.g., 30-day readmission rates), clinical outcomes (e.g., medication discrepancies, MRPs, laboratory and clinical parameters) and humanistic outcomes (e.g., medication burden-related quality of life).

Conclusion

This review highlighted various types of MMS available for dialysis patients and their impact on ECHO. Key benefits include recognising medication discrepancies, reducing MRPs, improving laboratory and clinical parameters, lowering 30-day readmission rates and enhancing medication burden-related quality of life. However, limitations such as retrospective studies, English-only publications and limited comparison across MMS models highlight the need for additional robust and diverse research.

Reporting Method

This integrative review was conducted in accordance with the PRISMA statement.

Patient or Public Contribution

No Patient or Public Contribution.

❌